Treatment of unilateral olfactory neuroblastoma: Appropriate extent of surgical resection and potential for olfactory preservation.
Harish DharmarajanGarret W Choby GRalph Abi HachemEdward Cheng-Lung KuanCorinna G LevineOlabisi SanusiTheodore A SchumanDennis TangMichael YimMathew GeltzeilerPublished in: International forum of allergy & rhinology (2024)
Historically, comprehensive surgical resection for olfactory neuroblastoma has included the bilateral olfactory epithelium, cribriform plate, overlying dura, olfactory bulbs and tracts. This results in postoperative anosmia that may significantly impact a patient's quality of life without definitive added benefit in survival. The prevalence of occult intracranial disease is low, especially for Hyams grade I and II tumors. A unilateral approach sparing the contralateral cribriform plate and olfactory system can be considered for select cases of early stage, low-grade tumors when the disease does not cross midline to involve the contralateral olfactory cleft or septal mucosa and when midline dural margins can be cleared with frozen pathology. Approximately half of patients who undergo unilateral resection may have residual olfaction even with adjuvant unilateral radiation. Early data suggest favorable disease-free survival and overall survival for patients who underwent the unilateral approach; however, larger sample studies are needed to confirm comparability to bilateral resections regarding oncologic outcomes.
Keyphrases
- free survival
- early stage
- low grade
- case report
- high grade
- end stage renal disease
- ejection fraction
- newly diagnosed
- prostate cancer
- type diabetes
- heart failure
- chronic kidney disease
- radiation therapy
- big data
- machine learning
- squamous cell carcinoma
- risk factors
- metabolic syndrome
- adipose tissue
- patient reported outcomes
- risk assessment
- neoadjuvant chemotherapy
- deep learning
- lymph node
- glycemic control